Actinium Pharmaceuticals, Inc.ATNMNYSE
Loading
Net Income ContractionContracting
Percentile Rank13
Studio
Year-over-Year Change

Total earnings after all expenses, taxes, and interest

Latest
$-34.60M
↓ 16% vs avg
Percentile
P13
Within normal range
Streak
2 yr
Consecutive growthContracting
Average
$-29.81M
Historical baseline
PeriodValueYoY Change
TTM$-34.60M+9.5%
2024$-38.24M+21.7%
2023$-48.82M-47.9%
2022$-33.02M-33.3%
2021$-24.77M-11.5%
2020$-22.21M-1.4%
2019$-21.90M+7.4%
2018$-23.65M+11.1%
2017$-26.60M-9.4%
2016$-24.32M-